Personal tools
Log in

Skip to content. | Skip to navigation

Sections
You are here: Home Library Health Topics Collection Guidelines Practice parameter: pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. American Academy of Neurology. Child Neurology Society. NGC:007677
Document Actions

Practice parameter: pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. American Academy of Neurology. Child Neurology Society. NGC:007677

Publication Details
Author(s):
  • AHRQ (US) - Agency for Healthcare Research and Quality
Country(ies) of application:
  • United States
Language(s):
  • English
Type of Publication:
Guideline Clearing Report
Primary Contact:
Jean R. Slutsky, P.A., M.S.P.H.
jslutsky@ahrq.gov
Publication URL:
Open Publication URL in a new window
Publication Scope:
  • Assessment/diagnosis
  • Management
Publication Status:
Published
Date of publication:
Jan 26, 2010
Due for Review:
-
Diseases / Conditions Addressed
MeSH Terms addressed:
  • Musculoskeletal Diseases (C05)
    • Muscular Diseases (C05.651)
  • Neurological Disorders / Nervous System Diseases (C10)
    • Central Nervous System Diseases (C10.228)
    • Neurologic Manifestations (C10.597)
  • Signs and Symptoms (C23.888)
    • Neurologic Manifestations (C23.888.592)
  • Pharmacologic Actions (D27.505)
    • Central Nervous System Agents (D27.505.954.427)
  • Pediatrics (G02.403.776.610)
Guideline key questions
Page last updated: Nov 14, 2010

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.